Clinical Research Directory
Browse clinical research sites, groups, and studies.
Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Sponsor: Singapore General Hospital
Summary
Lifestyle change is key to diabetes management but there are limited resources and time to support patients in improving lifestyle behaviour in the current healthcare system. Currently, health coaching for behavioural chance guided by continuous glucose data, wearable and lifestyle data is not available in primary and tertiary care management of diabetes. This parallel-group randomised controlled trial (RCT) aims to investigate the effectiveness of a novel multi-component model of care comprising interventions including the mobile app EMPOWER and smartwatch, health coaching, and continuous glucose monitoring (CGM).
Official title: Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Key Details
Gender
All
Age Range
21 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2023-10-24
Completion Date
2024-12
Last Updated
2024-04-17
Healthy Volunteers
No
Conditions
Interventions
Continuous glucose monitoring and health coaching
Each CGM device will work for 14 days. The participants will use the CGM devices for the first two-week period in the first three months of the trial, and the first two-week period of the second three months of the trial. Participants will interact with health coach throughout the study duration.
EMPOWER mobile app
Nudges will be delivered through the EMPOWER mobile app. Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.
Locations (3)
Singapore General Hospital
Singapore, Singapore
National Heart Centre Singapore
Singapore, Singapore
Sengkang General Hospital
Singapore, Singapore